‹ All Posts
Umang Bhutada

12th Apr · SEBI-Registered Analyst

Sun Pharmaceutical Industries Ltd – Defensive Buying Support

SUNPHARMA
Sun Pharma shares rose ~0.8%, outperforming in a mixed market as investors rotated towards defensive sectors. Strong specialty portfolio and steady global demand continue to provide earnings stability. Pharma remains a preferred space during volatility, supporting consistent buying interest in stocks like Sun Pharma.

#StockInNews
997 likes·54 comments